CoChat

Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data

Open access

Published version of a preprint

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

PURPOSE: Spinal muscular atrophy (SMA), caused by loss of the SMN1 gene, is a leading cause of early childhood death. Due to the near identical sequences of SMN1 and SMN2, analysis of this region is challenging. Population-wide SMA screening to quantify the SMN1 copy number (CN) is recommended by the American College of Medical Genetics and Genomics. METHODS: We developed a method that accurately identifies the CN of SMN1 and SMN2 using genome sequencing (GS) data by analyzing read depth and eight informative reference genome differences between SMN1/2. RESULTS: We characterized SMN1/2 in 12,747 genomes, identified 1568 samples with SMN1 gains or losses and 6615 samples with SMN2 gains or losses, and calculated a pan-ethnic carrier frequency of 2%, consistent with previous studies. Additionally, 99.8% of our SMN1 and 99.7% of SMN2 CN calls agreed with orthogonal methods, with a recall of 100% for SMA and 97.8% for carriers, and a precision of 100% for both SMA and carriers. CONCLUSION: This SMN copy-number caller can be used to identify both carrier and affected status of SMA, enabling SMA testing to be offered as a comprehensive test in neonatal care and an accurate carrier screening tool in GS sequencing projects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41436-020-0754-0

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Common copy-number variants (CNVs) affecting the SMN1/2 loci. a Depth profiles across the SMN1/SMN2 regions. Samples with a total SMN1 + SMN2 copy number of 2, 3, 4, and 5 (derived from average read depth in the two genes) are shown as green, blue, black, and orange dots, respectively. Depth from 50 samples are summed up for each CN category. Each dot represents normalized depth values in a 100-bp window. Read counts are calculated in each 100-bp window, summing up reads from both SMN1 and SMN2, and normalized to the depth of wild-type samples (CN = 4). The SMN exons are represented as purple boxes. The two x-axes show coordinates (hg19) in SMN1 (bottom) and SMN2 (upper). b Depth profiles aggregated from 50 samples carrying a deletion of exons 7 and 8 are shown as red dots. Read depths are calculated in the same way as in (a).
Fig. 1 Common copy-number variants (CNVs) affecting the SMN1/2 loci. a Depth profiles across the SMN1/SMN2 regions. Samples with a total SMN1 + SMN2 copy number of 2, 3, 4, and 5 (derived from average read depth in the two genes) are shown as green, blue, black, and orange dots, respectively. Depth from 50 samples are summed up for each CN category. Each dot represents normalized depth values in a 100-bp window. Read counts are calculated in each 100-bp window, summing up reads from both SMN1 and SMN2, and normalized to the depth of wild-type samples (CN = 4). The SMN exons are represented as purple boxes. The two x-axes show coordinates (hg19) in SMN1 (bottom) and SMN2 (upper). b Depth profiles aggregated from 50 samples carrying a deletion of exons 7 and 8 are shown as red dots. Read depths are calculated in the same way as in (a).CC BY-NC-ND · PubMed Central
Fig. 2 Scatterplot of total SMN (SMN1, SMN2, and SMN2∆7–8) copy number (CN) (x-axis, called by read depth in exons 1–6) and intact SMN copy number (y-axis, called by read depth in exons 7–8).
Fig. 2 Scatterplot of total SMN (SMN1, SMN2, and SMN2∆7–8) copy number (CN) (x-axis, called by read depth in exons 1–6) and intact SMN copy number (y-axis, called by read depth in exons 7–8).CC BY-NC-ND · PubMed Central
Fig. 3 Distribution of SMN1/SMN2/SMN2∆7–8 copy numbers in the population. a Percentage of samples showing copy number (CN) call agreement with c.840C>T across 16 SMN1–SMN2 base difference sites in African and non-African populations. Coordinates of these 16 sites are given in Table S1 and site 13* is the c.840C>T splice variant site. The black horizontal line denotes 85% concordance. b Histogram of the distribution of SMN1, SMN2, and SMN2∆7–8 copy numbers across five populations in 1kGP and the National Institute for Health Research (NIHR) BioResource cohort. c SMN1 CN vs. total SMN2 CN (intact SMN2 + SMN2∆7–8). d Two trios with an SMA proband detected by the caller and orthogonally confirmed in the Next Generation Children project cohort. CNs of SMN1, SMN2, and SMN2∆7–8 are phased and labeled for each member of the trios.
Fig. 3 Distribution of SMN1/SMN2/SMN2∆7–8 copy numbers in the population. a Percentage of samples showing copy number (CN) call agreement with c.840C>T across 16 SMN1–SMN2 base difference sites in African and non-African populations. Coordinates of these 16 sites are given in Table S1 and site 13* is the c.840C>T splice variant site. The black horizontal line denotes 85% concordance. b Histogram of the distribution of SMN1, SMN2, and SMN2∆7–8 copy numbers across five populations in 1kGP and the National Institute for Health Research (NIHR) BioResource cohort. c SMN1 CN vs. total SMN2 CN (intact SMN2 + SMN2∆7–8). d Two trios with an SMA proband detected by the caller and orthogonally confirmed in the Next Generation Children project cohort. CNs of SMN1, SMN2, and SMN2∆7–8 are phased and labeled for each member of the trios.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 145

Metadata

Authors
Chen, X., Sanchis-Juan, A., French, C. E., Connell, A. J., Delon, I., Kingsbury, Z., Chawla, A., Halpern, A. L., Taft, R. J., Bentley, D. R., Butchbach, M. E. R., Raymond, F. L., & Eberle, M. A.
Affiliations
  • Illumina (United States) (US)
  • University of Cambridge (GB)
  • Alfred I. duPont Hospital for Children (US)
  • Cambridge University Hospitals NHS Foundation Trust (GB)
  • Illumina (United Kingdom) (GB)
Corresponding author
Eberle, Michael A.
Venue
Genetics in Medicine
Publisher
Elsevier BV
Published
2020-05
Volume
22
Issue
5
Pages
945-953
ISSN
1098-3600 (ISSN-L)
OpenAlex
W3005935937
Cited by
137
References
39
Citations by year
2026: 14 · 2025: 24 · 2024: 26 · 2023: 23 · 2022: 21 · 2021: 20 · 2020: 9
FWCI
9.44
Type
journal article
Language
en
Open access
Licence
Locations
  • Genetics in Medicine (publishedVersion, cc-by-nc-nd)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • Apollo (University of Cambridge) (submittedVersion, cc-by-nc-nd)
  • Apollo
Funders
  • NHS Blood and Transplant
  • Nemours Foundation
  • New York Genome Center
  • National Institute for Health and Care Research (NIHR200254, RG65966)
  • Department of Health and Social Care
  • Cambridge University Hospitals (146281)
  • National Institutes of Health
  • NIHR BioResource (RG65966)
  • NIHR Cambridge Biomedical Research Centre
  • National Human Genome Research Institute (UM1HG008901)
  • National Institute of General Medical Sciences (P30GM114736, P20GM103446)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
spinal muscular atrophy, SMN1 copy number, SMN2 copy number, carrier screening, sequencing depth, genome sequencing data, newborn screening
MeSH terms
Base Sequence, Child, Child, Preschool, Humans, Muscular Atrophy, Spinal, Survival of Motor Neuron 1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data. https://app.cochat.ai/papers/10.1038/s41436-020-0754-0
The paper
Chen, X., Sanchis-Juan, A., French, C. E., Connell, A. J., Delon, I., Kingsbury, Z., Chawla, A., Halpern, A. L., Taft, R. J., Bentley, D. R., Butchbach, M. E. R., Raymond, F. L., & Eberle, M. A. (2020). Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data. Genetics in Medicine. https://doi.org/10.1038/s41436-020-0754-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.